Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications (Q35062320)

6 August 2017

1 reference

title

Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications (English)

1 reference

6 August 2017

Angelo M Scanu

1

1 reference

6 August 2017

publication date

1 March 2003

1 reference

Current Atherosclerosis Reports

6 August 2017

published in

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

106-113

1 reference

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0081-3

A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0081-3

The response-to-retention hypothesis of early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0081-3

Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0081-3

Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0081-3

Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries

21 January 2018

1 reference

12 December 2020

Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations

1 reference

12 December 2020

The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium

1 reference

12 December 2020

Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation.

1 reference

12 December 2020

The endothelium and lipoproteins: insights from recent cell biology and animal studies

1 reference

12 December 2020

Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)

1 reference

12 December 2020

Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans

1 reference

12 December 2020

Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.

1 reference

12 December 2020

Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.

1 reference

12 December 2020

Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease

1 reference

12 December 2020

Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments

1 reference

12 December 2020

Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice

1 reference

12 December 2020

CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells

1 reference

12 December 2020

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

1 reference

12 December 2020

Effect of phospholipase A2 digestion on the conformation and lysine/fibrinogen binding properties of human lipoprotein[a]

1 reference

12 December 2020

Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).

1 reference

12 December 2020

Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.

1 reference

12 December 2020

Atherothrombogenicity of lipoprotein(a): the debate

1 reference

12 December 2020

Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a]

1 reference

12 December 2020

Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians

1 reference

12 December 2020

Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages

1 reference

12 December 2020

Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population

1 reference

12 December 2020

Novel therapeutic strategy for atherosclerosis: ribozyme oligonucleotides against apolipoprotein(a) selectively inhibit apolipoprotein(a) but not plasminogen gene expression

1 reference

12 December 2020

Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice

1 reference

12 December 2020

Phospholipase A2 modification enhances lipoprotein(a) binding to the subendothelial matrix

1 reference

12 December 2020

Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity

1 reference

12 December 2020

Dominant role of the C-terminal domain in the binding of apolipoprotein(a) to the protein core of proteoglycans and other members of the vascular matrix

1 reference

12 December 2020

Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology

1 reference

12 December 2020

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

1 reference

12 December 2020

Lipoprotein(a): intrigues and insights

1 reference

12 December 2020

Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes

1 reference

12 December 2020

Clinical implications of elevated lipoprotein(a)

1 reference

12 December 2020

Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain

1 reference

12 December 2020

Lp(a): an interloper into the fibrinolytic system?

1 reference

12 December 2020

Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease

1 reference

12 December 2020

Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDL independently of apolipoprotein(a) size

1 reference

12 December 2020

Atherosclerosis in a rhesus monkey with genetic hypercholesterolemia and elevated plasma Lp(a)

1 reference

12 December 2020

Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor

1 reference

12 December 2020

Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity

1 reference

12 December 2020

Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study

1 reference

12 December 2020

Enzymatic probes of lipoprotein structure. Hydrolysis of human serum low density lipoprotein-2 by phospholipase A2

1 reference

12 December 2020

Lipolysis of LDL by Human Secretory Phospholipase A 2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans

1 reference

12 December 2020

Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis

1 reference

12 December 2020

Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.

1 reference

12 December 2020

Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels

1 reference

12 December 2020

Apolipoprotein(a): structure and biology.

1 reference

12 December 2020

Enhanced atherosclerosis in Lp(a) WHHL transgenic rabbits.

1 reference

12 December 2020

The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events

1 reference

12 December 2020

Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors

1 reference

12 December 2020

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor

1 reference

12 December 2020

Apolipoprotein (a) alleles determine lipoprotein (a) particle density and concentration in plasma

1 reference

12 December 2020

Apolipoprotein (a) fragments in relation to human carotid plaque instability

1 reference

12 December 2020

Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet

1 reference

12 December 2020

Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo

1 reference

12 December 2020

Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance

1 reference

12 December 2020

10.1007/S11883-003-0081-3

Identifiers

DOI

1 reference

6 August 2017

1 reference